Nasdaq Markets

(RTTNews) - Euronext (ENXB.BE, ENX.BR, ENX.AS, ENX.PA) Monday confirmed that it has submitted a non-binding offer to London Stock Exchange Group plc to acquire Borsa Italiana.

(RTTNews) - Evotec SE (EVTCY.PK, EVOTF.PK), on Monday, announced that it has entered into a partnership with the French-based BIOASTER Technological Research Institute to advance research for infectious diseases.

(RTTNews) - Nestlé, S.A (NSRGY.OB) announced Monday that its unit Sociétés des Produits Nestlé S.A, through SPN Merger Sub, Inc., is commencing a cash tender offer to buy Aimmune Therapeutics, Inc. (AIMT).

(RTTNews) - Valneva and Dynavax Technologies Corp. (DVAX) have reached a commercial supply agreement for the potential COVID-19 Vaccine. Dynavax will supply its CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.

(RTTNews) - Higher European and U.S. futures following news about resumption of final stage clinical trial of coronavirus vaccine by AstraZeneca point to a firm start for European stocks Monday morning.

(RTTNews) - Chemical company Dow Inc. (DOW) announced Monday that it has entered into a definitive agreement to sell certain U.S. Gulf Coast marine and terminal operations and assets to Vopak Industrial Infrastructure Americas for $620 million.

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) announced Monday that Dupixent (dupilumab) has received Breakthrough Therapy designation from the U.S. Food and Drug Administration.

(RTTNews) - Indian shares opened on a buoyant note Monday morning, tracking positive cues from Asian markets and higher U.S. index futures, amid optimism about coronavirus vaccine.

(RTTNews) - Nvidia Corp. (NVDA) said Sunday that it will acquire chipmaker Arm Limited from SoftBank Group Corp and the SoftBank Vision Fund in a deal worth $40 billion.

(RTTNews) - ByteDance Ltd, the Chinese owner of TikTok, has selected Oracle to be the social video app's U.S. technology partner, and Oracle will take a significant stake in the business, according to reports citing people familiar with matter.

(RTTNews) - Asian stock markets are advancing on Monday despite the mixed cues from Wall Street Friday, as positive news on the coronavirus vaccine front boosted sentiment. Drug maker AstraZeneca said it has resumed the late-stage trial of its coronavirus vaccine candidate in th

(RTTNews) - Higher SGX Nifty futures point to a positive start for the Indian stock market on Monday.

Multiple drugmakers are in phase 3 clinical trials for their coronavirus vaccines -- the last stage before potential approval. Meanwhile, Merck (NYSE: MRK) is just now starting the first human study of its coronavirus vaccine, V591.

(RTTNews) - The Thai stock market has moved lower in five straight sessions, sinking more than 35 points or 2.7 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,280-point plateau and it's expected to spin its wheels again on Friday although it ma

Gilead Sciences' (NASDAQ: GILD) mission to create a better oncology portfolio took a big step forward on Sunday. The company best known for antiviral treatments made Immunomedics (NASDAQ: IMMU) a juicy buyout offer that values the recently successful cancer drug developer at $21

(RTTNews) - The Japanese stock market is advancing on Monday despite the mixed cues from Wall Street Friday. Investor sentiment was boosted by news that AstraZenece has resumed the late-stage trial of its coronavirus vaccine in the UK.

(RTTNews) - The Indonesia stock market on Friday ended the two-day losing streak in which it had plummeted more than 350 points or 7 percent. The Jakarta Composite Index now sits just above the 5,015-point plateau and it may add to its winnings on Monday.

(RTTNews) - The Australian stock market is rising on Monday despite the mixed cues from Wall Street Friday, as positive news on the coronavirus vaccine front boosted sentiment. AstraZeneca said it has resumed the late-stage trials of its coronavirus vaccine in the UK after recei

(RTTNews) - Gilead Sciences Inc. (GILD) agreed to buy Immunomedics (IMMU) for $88.00 per share in cash, valuing the company at about $21 billion, the two companies said in a statement on Sunday.

(RTTNews) - The Hong Kong stock market on Friday ended the two-day losing streak in which it had fallen more than 310 points or 1.3 percent along the way. The Hang Seng Index now rests just above the 24,500-point plateau and it's expected to remain in that neighborhood on Monday